N

Novasenta

18 employees

Novasenta develops treatments to transform the lives of patients with cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
therapeutics
Health Care
Therapeutics
Medical
metabolism
cancer
immunology
Life Science
healthcare
biotech

Date founded

2019

Funding rounds raised

Total raised

$40M

from 1 investors over 1 rounds

N

Novasenta raised $40M on July 29, 2022

Investors: UPMC Enterprises

FAQ